You have 9 free searches left this month | for more free features.

ak002

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Eosinophilic Gastritis, Eosinophilic Gastroenteritis, Eosinophilic Duodenitis Trial in United States (AK002)

Active, not recruiting
  • Eosinophilic Gastritis
  • +2 more
  • AK002
  • Phoenix, Arizona
  • +16 more
Jun 21, 2021

Eosinophilic Duodenitis, Eosinophilic Gastroenteritis Trial in United States (AK002, Placebo)

Active, not recruiting
  • Eosinophilic Duodenitis
  • Eosinophilic Gastroenteritis
  • AK002
  • Placebo
  • Birmingham, Alabama
  • +38 more
Dec 16, 2021

Atopic Dermatitis Trial in United States (AK002, Placebo)

Recruiting
  • Atopic Dermatitis
  • AK002
  • Placebo
  • Birmingham, Alabama
  • +47 more
Aug 18, 2022

Eosinophilic Gastritis, Eosinophilic Duodenitis Trial in United States (AK002, Placebo)

Recruiting
  • Eosinophilic Gastritis
  • Eosinophilic Duodenitis
  • AK002
  • Placebo
  • Birmingham, Alabama
  • +73 more
Dec 9, 2021

Chronic Urticaria Trial in Germany, United States (AK002)

Completed
  • Chronic Urticaria
  • AK002
  • Edgewater, Florida
  • +3 more
May 19, 2020

Eosinophilic Gastritis, Eosinophilic Gastroenteritis Trial in United States (AK002, Placebo)

Completed
  • Eosinophilic Gastritis
  • Eosinophilic Gastroenteritis
  • AK002
  • Placebo
  • Phoenix, Arizona
  • +20 more
Jun 10, 2020

Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, Perennial Allergic Conjunctivitis Trial in United States (AK002)

Completed
  • Atopic Keratoconjunctivitis
  • +2 more
  • AK002
  • Palo Alto, California
  • +7 more
Aug 28, 2019

Indolent Systemic Mastocytosis Trial in Berlin (AK002)

Completed
  • Indolent Systemic Mastocytosis
  • AK002
  • Berlin, Germany
    Charité - Universitätsmedizin Berlin
Mar 12, 2019

Healthy Trial in Melbourne (AK002, Placebo)

Completed
  • Healthy
  • AK002
  • Placebo
  • Melbourne, Australia
    Nucleus Network Limited
Sep 25, 2017